Craig Anthony Cummings

Title: Craig Anthony Cummings: Innovator in Cancer Therapeutics

Introduction

Craig Anthony Cummings is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on therapeutic and diagnostic methods that aim to improve cancer treatment outcomes.

Latest Patents

Cummings holds a patent for "Therapeutic and diagnostic methods for cancer." This invention provides various methods for treating cancer, determining the likelihood of an individual responding to immune checkpoint inhibitors, predicting treatment responsiveness, selecting appropriate therapies, and monitoring patient responses based on specific genetic markers. His patent emphasizes the importance of blood tumor mutational burden (bTMB) scores and maximum somatic allele frequency (MSAF) in guiding treatment decisions.

Career Highlights

Throughout his career, Cummings has worked with prominent companies in the biotechnology sector. He has been associated with Genentech, Inc. and Foundation Medicine, Inc., where he has contributed to advancing cancer research and treatment methodologies. His expertise in the field has positioned him as a valuable asset in the fight against cancer.

Collaborations

Cummings has collaborated with notable professionals in the industry, including Yan Li and Sarah Margaret Shagan. These collaborations have further enriched his research and development efforts in cancer therapeutics.

Conclusion

Craig Anthony Cummings is a distinguished inventor whose work in cancer therapeutics has the potential to transform treatment approaches. His innovative patent and collaborations with leading companies and professionals highlight his commitment to improving patient outcomes in oncology.